Life Science Company News

Reset
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Recce Pharmaceuticals Ltd

Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Pacira BioSciences, Inc

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Nautilus Biotechnology Inc.

Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Inspire Medical Systems, Inc. | Insplorion AB

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Vaxart, Inc

Alumis Announces First Participant Dosed in Phase 1 Clinical Trial of CNS Penetrant Allosteric TYK2 Inhibitor A-005

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Alumis Inc.

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Intra-Cellular Therapies, Inc.

Goodness Growth Holdings to Release First Quarter 2024 Results on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Noom Establishes Its First-Ever Social Impact Program with the Launch of Noom Impact, Providing Free Health Solutions to People in Need

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Noom Inc.

Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Senti Biosciences

STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  STRATA Skin Sciences, Inc.

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  BioStem Technologies, Inc.

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  SeaStar Medical

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Orchestra BioMed, Inc.

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Veru Inc.

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Wave Life Sciences USA, Inc.

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Fractyl Health, Inc.

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia

Read more ››
By: GlobeNewswire - 30 Apr 2024

ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  ALX Oncology, Inc.

Nacuity Pharmaceuticals Announces First Patients Implanted in Final Cohort of Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Nacuity Pharmaceuticals, Inc.
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »